Biome Achieves Record Quarter, Half and Full-Year Sales Revenue (unaudited)

● Biome records
○ ~$13m FY24 sales revenue, up 80% vs PCP
○ ~$7m H2 FY24 sales revenue, up 82% vs PCP
○ ~$3.8m Q4 FY24 sales revenue, up 88% vs PCP
● FY24 sales revenue ~$500k ahead of upgraded FY24 forecast ($12.5m)
● Q4 FY24 sales revenue tracking at an annualised run rate of ~$15m
● Biome will report its third consecutive quarter of positive cash flow and
second consecutive quarter of positive EBITDA
● Pharmacy retail scan sales of Activated Probiotics (Pharmacy RRP), from
May 2023 through to May 2024, reached ~$12m and is the number-one
brand for growth in the category